5Liaw YF, Leung N, Guan R, et al. Asian-Pacific on the management of chronic hepatitis B: a 2005update[J]. Liver Int, 2005, 25(3): 472 - 489.
6Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: treatment of hepatitisB infection reduces risk of hepatocellular carcinoma[J]. Aliment PharmacolTher, 2008, 28 (9): 1067 - 1077.
7Mok TS, Yeo W, Yu S, et al. An intensive surveillance programdetected a high incidence of hepatocellular carcinoma among hepatitisB virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results[J]. J Clin Oncol, 2005, 23 (31): 8041-8047.
8Wong GL, Wong VW, Tan GM, et al. Surveillance programmeforhepatocellular carcinoma improves the survival of patients withchronic viral hepatitis[J]. Liver Int, 2008, 28 (1): 79-87.
9Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study[J]. Lancet, 2001, 357(9262): 1069-1075.
10Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study[J]. Gastroenterology, 2004, 127(6): 1704-1713.
